Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06574347
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-25
Brief Title:
Vebreltinib Plus PLB1004 as the First-line Therapy for Patients With EGFRmMET Locally Advanced or Metastatic NSCLC
Sponsor:
None
Organization:
None
Conditions & Keywords Data
Conditions:
Keywords: